Shares of CVS Health (CVS) are doing well Monday, but have struggled for most of 2016, falling almost 15%. Investors are hoping the company's earnings results on Tuesday will help reverse their fortunes.
The stock's being hurt by the company's perceived weakness tied to its pharmacy business, TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, said from the floor of the New York Stock Exchange Monday.
So if management tells investors that its pharmacy isn't doing that bad and that the front of the store -- its convenience business -- is doing well, then investors should take that as a big positive.
Unfortunately for CVS, it's being viewed as a health care play, a sector that is under enormous pressure, rather than a drug store play, Cramer explained.
The stock would be favorably viewed and likely one investors want to buy if the CEO would outline a non-health care related vision for the business, Cramer concluded.
Analysts expect the company to earn $1.57 per share on $45.29 billion in revenue.